| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/28/1995 | WO1995025800A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors |
| 09/28/1995 | WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 09/28/1995 | WO1995025794A1 Anti-igf-i monoclonal antibody |
| 09/28/1995 | WO1995025785A1 EXPRESSION PLASMIDS REGULATED BY AN osmB PROMOTER |
| 09/28/1995 | WO1995025743A1 Enhanced secretion of polypeptides |
| 09/28/1995 | WO1995025740A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
| 09/28/1995 | WO1995025739A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
| 09/28/1995 | WO1995025543A1 Methods and compositions useful for inhibition of angiogenesis |
| 09/28/1995 | WO1995025535A1 Thyroxin-binding proteins |
| 09/28/1995 | WO1995025530A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 09/28/1995 | WO1995025528A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection |
| 09/28/1995 | WO1995025437A1 Process for producing brightly-coloured vegetable protein hydrolysates |
| 09/28/1995 | WO1995025429A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
| 09/28/1995 | WO1995023860A3 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR |
| 09/28/1995 | WO1995023855A3 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 09/28/1995 | WO1994025597A3 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA) |
| 09/28/1995 | CA2186242A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors |
| 09/28/1995 | CA2186035A1 Thyroxin-binding proteins |
| 09/28/1995 | CA2186016A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection |
| 09/28/1995 | CA2186006A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 09/28/1995 | CA2186005A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
| 09/28/1995 | CA2185343A1 Enhanced secretion of polypeptides |
| 09/28/1995 | CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf) |
| 09/28/1995 | CA2162147A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
| 09/27/1995 | EP0674003A2 Modulatory proteins of human CNS receptors |
| 09/27/1995 | EP0673948A1 Pepticles derived from a retrovirus of the HIV-group and their use |
| 09/27/1995 | EP0673440A1 Mammalian muscle nad:arginine adp-ribosyltransferase |
| 09/27/1995 | EP0673426A1 Platelet-activating factor acetylhydrolase |
| 09/27/1995 | EP0673422A1 Cells with altered betaine catabolism, their preparation and their use, in particular for producing metabolites or enzymes |
| 09/27/1995 | EP0673421A1 Allergenic proteins and peptides from johnson grass pollen |
| 09/27/1995 | EP0673420A1 Mammalian receptors for interleukin-10 (il-10) |
| 09/27/1995 | EP0673419A1 Stably transfected cell lines expressing gaba-a receptors |
| 09/27/1995 | EP0673418A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| 09/27/1995 | EP0673415A1 Recombinant viral vector system |
| 09/27/1995 | EP0673414A1 Method for enhancing the differentiation of plant cells in culture |
| 09/27/1995 | EP0673390A1 Delta-like gene expressed in neuroendocrine tumors |
| 09/27/1995 | EP0673389A1 Antibodies for gm-csf receptor and uses thereof |
| 09/27/1995 | EP0673387A1 Materials and methods for control of pests |
| 09/27/1995 | EP0673386A1 Methods and compositions for detecting anti-hepatitis e virus activity |
| 09/27/1995 | EP0673255A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 09/27/1995 | EP0573554B1 Use of at least one purified peptide obtainable by hydrolysis of casein and having opioid activity as active principle in the manufacture of a cosmetic composition |
| 09/27/1995 | EP0348490B1 Treatment of type 2 diabetes mellitus |
| 09/27/1995 | CN1109260A A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
| 09/26/1995 | US5453491 Purified and comprising specified amino acid sequences; therapy for autoimmune disorders and eosinophilia |
| 09/26/1995 | US5453490 Production of recombinant human interleukin-1 inhibitor |
| 09/26/1995 | US5453489 Specific amino acid sequences; bind directly to fibronectin, reduces matrix assembly without affecting binding to cells; antitumor/wound healing agents |
| 09/26/1995 | US5453419 Xenopus laevis bone morphogenetic proteins and use thereof |
| 09/26/1995 | US5453373 Protein C derivatives |
| 09/26/1995 | US5453364 Recombinant poxvirus host range selection system |
| 09/26/1995 | US5453361 Method for producing biologically active human brain derived neurotrophic factor |
| 09/26/1995 | US5453359 Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers |
| 09/26/1995 | US5453273 M. canis containing ringworm vaccine |
| 09/26/1995 | CA2145623A1 Modulatory proteins of human cns receptors |
| 09/26/1995 | CA1337120C Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 09/21/1995 | WO1995025173A1 Methods for identifying inhibitors of integrin activation |
| 09/21/1995 | WO1995025172A1 Recombinant antibody fragments which are synthesized and biotinylated in e. coli, their use in immunoassays and immunopurification techniques |
| 09/21/1995 | WO1995025170A1 NOVEL MUTEINS OF IFN-$g(b) |
| 09/21/1995 | WO1995025168A1 Use of a recombinant inhibitor from erythrina caffra for purifying serine proteases |
| 09/21/1995 | WO1995025167A1 Anti-egfr single-chain fvs and anti-egfr antibodies |
| 09/21/1995 | WO1995025165A1 cDNAs ENCODING MINOR AMPULLATE SPIDER SILK PROTEINS |
| 09/21/1995 | WO1995025125A1 Dna encoding cai resistance proteins and uses thereof |
| 09/21/1995 | WO1995025119A1 Stabilization of peptides and proteins for radiopharmaceutical use |
| 09/21/1995 | WO1995025114A1 Plant peptide transport gene |
| 09/21/1995 | WO1995024928A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 09/21/1995 | WO1995024918A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 09/21/1995 | WO1995024915A1 Product and process for regulating signal transduction pathways |
| 09/21/1995 | WO1995021858A3 Mosaic polypeptide and methods for detecting the hepatitis e virus |
| 09/21/1995 | WO1995021601A3 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
| 09/21/1995 | WO1995020663A3 THERMOSTABLE VARIANTS OF NEUTRAL PROTEASES OF BACILLUS STEAROTHERMOPHILUS AND $i(BACILLUS THERMOPROTEOLYTICUS) |
| 09/21/1995 | WO1995018826A3 Purified primate ctla-8 antigens and related reagents |
| 09/21/1995 | CA2207851A1 Plant peptide transport gene |
| 09/21/1995 | CA2185671A1 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 09/21/1995 | CA2185539A1 Blood-borne mesenchymal cells |
| 09/21/1995 | CA2185446A1 Methods for identifying inhibitors of integrin activation |
| 09/21/1995 | CA2185341A1 Dna encoding cai resistance proteins and uses thereof |
| 09/21/1995 | CA2184631A1 Product and process for regulating signal transduction pathways |
| 09/20/1995 | EP0672756A1 Monoclonal antibody recognizing fk506-binding protein, method of assaying fk506-binding protein level, and kit thereof |
| 09/20/1995 | EP0672685A2 Monoclonal antibody |
| 09/20/1995 | EP0672683A1 Macif protein, genes coding therefor, expression vectors containing said genes, and transformant cells containing said protein |
| 09/20/1995 | EP0672681A1 Novel antitumor peptide |
| 09/20/1995 | EP0672253A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor |
| 09/20/1995 | EP0672176A1 A method for amplifying and detecting a target nucleic acid sequence of hiv-1 |
| 09/20/1995 | EP0672156A1 Bovine heat shock promoter and uses thereof |
| 09/20/1995 | EP0672152A1 Fusion proteins comprising mgf and il-3 |
| 09/20/1995 | EP0672150A1 Modified kluyveromyces yeasts, their preparation and use |
| 09/20/1995 | EP0672148A1 Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom |
| 09/20/1995 | EP0672147A1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 09/20/1995 | EP0672146A1 Biocidal chitin binding proteins |
| 09/20/1995 | EP0672145A1 Interleukin-3 (il-3) multiple mutation polypeptides |
| 09/20/1995 | EP0672144A1 Interleukin-6 receptor antagonists |
| 09/20/1995 | EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 09/20/1995 | EP0672142A1 Multivalent and multispecific binding proteins, their manufacture and use |
| 09/20/1995 | EP0672141A1 Methods of preparing soluble, oligomeric proteins |
| 09/20/1995 | EP0672140A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM |
| 09/20/1995 | EP0672139A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 09/20/1995 | EP0672136A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 09/20/1995 | EP0672134A1 Peptides useful for inducing tolerance |
| 09/20/1995 | EP0672132A1 Receptor internalization signals |
| 09/20/1995 | EP0672131A1 Interaction trap system for isolating novel proteins |
| 09/20/1995 | EP0672130A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |